Clarius Group, LLC Gsk PLC Transaction History

Clarius Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$42.05 - $47.77 $14,086 - $16,002	335 Added 5.65%	6,269 $273,000
Q4 2021 Feb 02, 2022	BUY	$38.88 - $45.31 $230,713 - $268,869	5,934 New	5,934 $262,000
Q3 2020 Oct 09, 2020	SELL	$38.11 - $42.99 $191,769 - $216,325	-5,032 Closed	0 $0
Q2 2020 Jul 08, 2020	SELL	$37.87 - $43.58 $27,796 - $31,987	-734 Reduced 12.73%	5,032 $205,000
Q1 2020 Apr 24, 2020	SELL	$32.47 - $48.83 $20,715 - $31,153	-638 Reduced 9.96%	5,766 $218,000
Q4 2019 Jan 22, 2020	SELL	$42.0 - $48.25 $336 - $386	-8 Reduced 0.12%	6,404 $305,000
Q3 2019 Oct 23, 2019	BUY	$40.46 - $43.52 $33,258 - $35,773	822 Added 14.7%	6,412 $274,000
Q2 2019 Aug 02, 2019	BUY	$39.4 - $42.7 $220,246 - $238,693	5,590 New	5,590 $224,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarius Group, LLC with notifications on news.